These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37225093)

  • 1. Mortality after catheter ablation of structural heart disease related ventricular tachycardia.
    Bennett RG; Garikapati K; Campbell TG; Kotake Y; Turnbull S; Bhaskaran A; De Silva K; Kanawati J; Zhou J; Wong MS; Kumar S
    Int J Cardiol; 2023 Sep; 386():50-58. PubMed ID: 37225093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes in Patients With Dilated Cardiomyopathy and Ventricular Tachycardia.
    Zeppenfeld K; Wijnmaalen AP; Ebert M; Baldinger SH; Berruezo A; Catto V; Vaseghi M; Arya A; Kumar S; de Riva M; Deneke T; Gaspar T; Soejima K; van Rein N; Tedrow UB; Piorkowski C; Shivkumar K; Carbucicchio C; Hindricks G; Stevenson WG
    J Am Coll Cardiol; 2022 Sep; 80(11):1045-1056. PubMed ID: 36075673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation Outcomes and Predictors of Mortality Following Catheter Ablation for Ventricular Tachycardia: Data From the German Multicenter Ablation Registry.
    Tilz RR; Lin T; Eckardt L; Deneke T; Andresen D; Wieneke H; Brachmann J; Kääb S; Chun KRJ; Münkler P; Lewalter T; Hochadel M; Senges J; Kuck KH
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29572321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleomorphic Ventricular Tachycardia in Dilated Cardiomyopathy Predicts Ventricular Tachycardia Recurrence After Ablation Independent From Cardiac Function: Comparison With Patients With Ischemic Heart Disease.
    Kimura Y; de Riva M; Ebert M; Glashan C; Wijnmaalen AP; Piers SR; Dekkers OM; Trines SA; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2023 Jan; 16(1):e010826. PubMed ID: 36595629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes after catheter ablation of ventricular tachycardia in patients with and without structural heart disease.
    Kumar S; Romero J; Mehta NK; Fujii A; Kapur S; Baldinger SH; Barbhaiya CR; Koplan BA; John RM; Epstein LM; Michaud GF; Tedrow UB; Stevenson WG
    Heart Rhythm; 2016 Oct; 13(10):1957-63. PubMed ID: 27392945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Prospective, Multicentre Randomised Controlled Trial Comparing Catheter Ablation Versus Antiarrhythmic Drugs in Patients With Structural Heart Disease Related Ventricular Tachycardia: The CAAD-VT Trial Protocol.
    ; Bennett RG; Campbell T; Garikapati K; Kotake Y; Turnbull S; Kanawati J; Wong MS; Qian P; Thomas SP; Chow CK; Kovoor P; Robert Denniss A; Chik W; Marschner S; Kistler P; Haqqani H; Rowe M; Voskoboinik A; Lee G; Jackson N; Sanders P; Roberts-Thomson K; Chan KH; Sy R; Pathak R; Kanagaratnam L; Chia K; El-Sokkari I; Hallani H; Kanthan A; Burgess D; Kumar S
    Heart Lung Circ; 2023 Feb; 32(2):184-196. PubMed ID: 36599791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of catheter ablation in post-infarction recurrent ventricular tachycardia.
    Haanschoten DM; Smit JJJ; Adiyaman A; Ramdat Misier AR; Hm Delnoy PP; Elvan A
    Scand Cardiovasc J; 2019 Apr; 53(2):62-70. PubMed ID: 30916588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of ventricular tachycardia ablation in patients with structural heart disease: The impact of electrical storm.
    Aldhoon B; Wichterle D; Peichl P; Čihák R; Kautzner J
    PLoS One; 2017; 12(2):e0171830. PubMed ID: 28187168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes with prophylactic use of percutaneous left ventricular assist devices in high-risk patients undergoing catheter ablation of scar-related ventricular tachycardia: A propensity-score matched analysis.
    Muser D; Liang JJ; Castro SA; Hayashi T; Enriquez A; Troutman GS; McNaughton NW; Supple G; Birati EY; Schaller R; Garcia FC; Frankel DS; Dixit S; Callans DJ; Zado ES; Marchlinski FE; Santangeli P
    Heart Rhythm; 2018 Oct; 15(10):1500-1506. PubMed ID: 29753944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
    Siontis KC; Santangeli P; Muser D; Marchlinski FE; Zeppenfeld K; Hoogendoorn JC; Narasimhan C; Sauer WH; Zipse MM; Kapa S; Vedantham V; Rosenthal DG; Robinson MR; Patton KK; Murgatroyd F; Chicos AB; Soejima K; Roukoz H; Sacher F; Bhan A; Appelbaum J; Dickfeld T; Mankad P; Ellenbogen KA; Kron J; Kim HM; Froehlich J; Eagle KA; Bogun FM; Crawford TC
    JAMA Cardiol; 2022 Feb; 7(2):175-183. PubMed ID: 34787643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients.
    Acosta J; Cabanelas N; Penela D; Fernández-Armenta J; Andreu D; Borràs R; Korshunov V; Cabrera M; Vasanelli F; Arbelo E; Guasch E; Martínez M; Tolosana JM; Mont L; Berruezo A
    Europace; 2017 Jun; 19(6):976-982. PubMed ID: 27353322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone Discontinuation or Dose Reduction Following Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease.
    Liang JJ; Yang W; Santangeli P; Schaller RD; Supple GE; Hutchinson MD; Garcia F; Lin D; Dixit S; Epstein AE; Callans DJ; Marchlinski FE; Frankel DS
    JACC Clin Electrophysiol; 2017 May; 3(5):503-511. PubMed ID: 29759607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after repeat ablation of ventricular tachycardia in structural heart disease: An analysis from the International VT Ablation Center Collaborative Group.
    Tzou WS; Tung R; Frankel DS; Di Biase L; Santangeli P; Vaseghi M; Bunch TJ; Weiss JP; Tholakanahalli VN; Lakkireddy D; Vunnam R; Dickfeld T; Mathuria N; Tedrow U; Vergara P; Vakil K; Nakahara S; Burkhardt JD; Stevenson WG; Callans DJ; Della Bella P; Natale A; Shivkumar K; Marchlinski FE; Sauer WH
    Heart Rhythm; 2017 Jul; 14(7):991-997. PubMed ID: 28506710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of baseline inducibility and activation mapping on ablation outcomes in patients with structural heart disease and ventricular tachycardia.
    Cano Ó; Pérez-Roselló V; Ayala HD; Izquierdo M; Osca J; Sancho-Tello MJ; Martínez-Dolz L
    J Cardiovasc Electrophysiol; 2021 May; 32(5):1328-1336. PubMed ID: 33834564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study.
    Tung R; Vaseghi M; Frankel DS; Vergara P; Di Biase L; Nagashima K; Yu R; Vangala S; Tseng CH; Choi EK; Khurshid S; Patel M; Mathuria N; Nakahara S; Tzou WS; Sauer WH; Vakil K; Tedrow U; Burkhardt JD; Tholakanahalli VN; Saliaris A; Dickfeld T; Weiss JP; Bunch TJ; Reddy M; Kanmanthareddy A; Callans DJ; Lakkireddy D; Natale A; Marchlinski F; Stevenson WG; Della Bella P; Shivkumar K
    Heart Rhythm; 2015 Sep; 12(9):1997-2007. PubMed ID: 26031376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter ablation of ventricular tachycardia in patients with prior cardiac surgery: An analysis from the International VT Ablation Center Collaborative Group.
    Aguilar M; Tedrow UB; Tzou WS; Tung R; Frankel DS; Santangeli P; Vaseghi M; Bunch TJ; Di Biase L; Tholakanahalli VN; Lakkireddy D; Dickfeld T; Weiss JP; Mathuria N; Vergara P; Nakahara S; Bradfield JS; Burkhardt JD; Stevenson WG; Callans DJ; Della Bella P; Natale A; Shivkumar K; Marchlinski FE; Sauer WH
    J Cardiovasc Electrophysiol; 2021 Feb; 32(2):409-416. PubMed ID: 33355965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the Storm: Comparison of Clinical Factors, Arrhythmogenic Substrate, and Catheter Ablation Outcomes in Structural Heart Disease Patients With versus Those Without a History of Ventricular Tachycardia Storm.
    Kumar S; Fujii A; Kapur S; Romero J; Mehta NK; Tanigawa S; Epstein LM; Koplan BA; Michaud GF; John RM; Stevenson WG; Tedrow UB
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):56-67. PubMed ID: 27781325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmia exacerbation after post-infarction ventricular tachycardia ablation: prevalence and prognostic significance.
    Siontis KC; Kim HM; Vergara P; Peretto G; Do DH; de Riva M; Lam A; Qian P; Yokokawa M; Jongnarangsin K; Latchamsetty R; Jais P; Sacher F; Tedrow U; Shivkumar K; Zeppenfeld K; Della Bella P; Stevenson WG; Morady F; Bogun FM
    Europace; 2020 Nov; 22(11):1680-1687. PubMed ID: 32830247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction and prognosis of ventricular tachycardia recurrence after catheter ablation with remote magnetic navigation for electrical storm in patients with ischemic cardiomyopathy.
    Jin Q; Jacobsen PK; Pehrson S; Chen X
    Clin Cardiol; 2017 Nov; 40(11):1083-1089. PubMed ID: 28817194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.